PR

Paul Rennert

GI Genetics Institute: 10 patents #33 of 327Top 15%
BM Biogen Idec Ma: 10 patents #12 of 270Top 5%
University of Michigan: 9 patents #167 of 4,352Top 4%
AB Aleta Biotherapeutics: 8 patents #4 of 12Top 35%
UF US Air Force: 7 patents #768 of 16,312Top 5%
DI Dana-Farber Cancer Institute: 3 patents #302 of 1,343Top 25%
RE Repligen: 3 patents #23 of 102Top 25%
AA Apoxis S. A.: 1 patents #6 of 16Top 40%
BI Biogen: 1 patents #81 of 174Top 50%
UM University of Minnesota: 1 patents #1,216 of 2,951Top 45%
📍 Holliston, MA: #12 of 324 inventorsTop 4%
🗺 Massachusetts: #2,653 of 88,656 inventorsTop 3%
Overall (All Time): #106,276 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 1–25 of 33 patents

Patent #TitleCo-InventorsDate
11891426 CD19 variants Roy Lobb, Benjamin Hackel, Justin Klesmith 2024-02-06
11807691 Compositions and methods for treatment of cancer Roy Lobb 2023-11-07
11207339 Targeted cancer therapy Roy Lobb, John T. Schiller 2021-12-28
11059904 Compositions and methods for tumor transduction Roy Lobb 2021-07-13
10669349 Compositions and methods for treatment of cancer Roy Lobb 2020-06-02
10508143 Compositions and methods for treatment of cancer Roy Lobb 2019-12-17
10072094 Compositions and methods for tumor transduction Roy Lobb 2018-09-11
10066023 Compositions and methods for tumor transduction Roy Lobb 2018-09-04
8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders 2013-05-14
8287874 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases Jeffrey Browning, Paula S. Hochman, Fabienne MacKay 2012-10-16
8206705 KIM-1 antibodies for treatment of TH2-mediated conditions Patricia McCoon, Veronique Bailly, Alexey Lugovskoy 2012-06-26
7744891 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases Jeffrey Browning, Paula S. Hochman, Fabienne MacKay 2010-06-29
7597887 KIM-1 antagonists and use to modulate immune system 2009-10-06
7592007 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies John Gribben, Gordon J. Freeman, Lee M. Nadler, Cindy L. Jellis, Edward A. Greenfield +1 more 2009-09-22
7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders 2009-08-25
7479269 Methods for selectively enriching TH1 and TH2 cells Carl H. June, Craig B. Thompson, Gary J. Nabel, Gary S. Gray 2009-01-20
7309492 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus Jeffrey Browning, Paula S. Hochman, Fabienne MacKay 2007-12-18
7276241 Methods of treating a tumor that expresses APRIL by administering BCMA Pascal Schneider, Jeffrey Thompson, Teresa G. Cachero, Christine Ambrose 2007-10-02
7255854 Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases Jeffrey Browning, Paula S. Hochman, Fabienne MacKay 2007-08-14
7232566 Methods for treating HIV infected subjects Carl H. June, Craig B. Thompson, Gary J. Nabel, Gary S. Gray 2007-06-19
7175843 Methods for selectively stimulating proliferation of T cells Carl H. June, Craig B. Thompson, Gary J. Nabel, Gary S. Gray 2007-02-13
7169387 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders 2007-01-30
7144575 Methods for selectively stimulating proliferation of T cells Carl H. June, Craig B. Thompson, Gary J. Nabel, Gary S. Gray 2006-12-05
6905680 Methods of treating HIV infected subjects Carl H. June, Craig B. Thompson, Gary J. Nabel, Gary S. Gray 2005-06-14
6905681 Methods for selectively stimulating proliferation of T cells Carl H. June, Craig B. Thompson, Gary J. Nabel, Gary S. Gray 2005-06-14